Briacell Therapeutics ISIN: CA1079303071 Forum: Aktien User: KapHeinz

Bin eingestiegen. Also eine Garantie das der Kurs fällt :-)

Ich seh schon… ich hab heute wieder Durchfall….. 😝😅 @abeni

BriaCell (Nasdaq: BCTX) reported that its pivotal Phase 3 study in metastatic breast cancer has screened >230 patients and enrolled >160, with enrollment exceeding expectations and strong site/patient interest. The company expects a topline interim data readout as early as 1H2026; the interim analysis will occur once 144 patient events (deaths) are observed and will assess overall survival (OS) versus physician’s choice. The Phase 3 regimen retains FDA Fast Track designation and positive results could support full approval and marketing authorization for Bria-IMT.

📌Long Kann richtig groß werden.